Abstract:Gene dosage variations occur in many diseases. In cancer, deletions and copy number increases contribute to alterations in the expression of tumour-suppressor genes and oncogenes, respectively. Developmental abnormalities, such as Down, Prader Willi, Angelman and Cri du Chat syndromes, result from gain or loss of one copy of a chromosome or chromosomal region. Thus, detection and mapping of copy number abnormalities provide an approach for associating aberrations with disease phenotype and for localizing critical genes. Comparative genomic hybridization3(CGH) was developed for genome-wide analysis of DNA sequence copy number in a single experiment. In CGH, differentially labelled total genomic DNA from a 'test' and a 'reference' cell population are cohybridized to normal metaphase chromosomes, using blocking DNA to suppress signals from repetitive sequences. The resulting ratio of the fluorescence intensities at a location on the 'cytogenetic map', provided by the chromosomes, is approximately proportional to the ratio of the copy numbers of the corresponding DNA sequences in the test and reference genomes. CGH has been broadly applied to human and mouse malignancies. The use of metaphase chromosomes, however, limits detection of events involving small regions (of less than 20 Mb) of the genome, resolution of closely spaced aberrations and linking ratio changes to genomic/genetic markers. Therefore, more laborious locus-by-locus techniques have been required for higher resolution studies2,3,4,5. Hybridization to an array of mapped sequences instead of metaphase chromosomes could overcome the limitations of conventional CGH (ref. 6) if adequate performance could be achieved. Copy number would be related to the test/reference fluorescence ratio on the array targets, and genomic resolution could be determined by the map distance between the targets, or by the length of the cloned DNA segments. We describe here our implementation of array CGH. We demonstrate its ability to measure copy number with high precision in the human genome, and to analyse clinical specimens by obtaining new information on chromosome 20 aberrations in breast cancer.

Simple copy number determination with reference query pyrosequencing (RQPS).

Rapid identification of homologous recombinants and determination of gene copy number with reference/query pyrosequencing (RQPS).

Ensemble of nucleic acid absolute quantitation modules for copy number variation detection and RNA profiling

Automated Design of Paralogue Ratio Test Assays for the Accurate and Rapid Typing of Copy Number Variation

DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly

CYP2D6 copy number determination using digital PCR

High resolution copy number inference in cancer using short-molecule nanopore sequencing

DCD-chip designed for the digital and ultraprecise quantification of copy number variation

A Study of Biases of DNA Copy Number Estimation Based on PICR Model

THE SCREENING AND RANKING ALGORITHM TO DETECT DNA COPY NUMBER VARIATIONS.

Multiplex Ligation-Dependent Sequence-Tag Amplification Coupled With Pyrosequencing For Copy Number Variation (Cnv) Analysis

CopywriteR: DNA copy number detection from off-target sequence data

Comparison of real-time quantitative PCR and two digital PCR platforms to detect copy number variation in FCGR3B

A Rapid PCR-Free Next-Generation Sequencing Method for the Detection of Copy Number Variations in Prenatal Samples

Copy number variation analysis based on gold magnetic nanoparticles and fluorescence multiplex ligation-dependent probe amplification

High Detection Rate of Copy Number Variations Using Capture Sequencing Data: A Retrospective Study

Pyrosequencing Templates Generated By Nicking Pcr Products With Nicking Endonuclease

High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

Pyrosequencing on Nicked Dsdna Generated by Nicking Endonucleases

Performance Assessment of Copy Number Microarray Platforms Using a Spike-in Experiment.

Copy number variation sequencing for comprehensive diagnosis of chromosome disease syndromes.